METTL14 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.26019999885574E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.479730E-03 |
Normal-vs-Stage2 |
2.835400E-03 |
Normal-vs-Stage3 |
2.6416646647931E-12 |
Normal-vs-Stage4 |
2.32702745961433E-13 |
Stage1-vs-Stage2 |
1.533420E-01 |
Stage1-vs-Stage3 |
1.60779999980321E-07 |
Stage1-vs-Stage4 |
1.89779999493211E-08 |
Stage2-vs-Stage3 |
6.635600E-02 |
Stage2-vs-Stage4 |
1.355810E-02 |
Stage3-vs-Stage4 |
2.789200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
7.32289995308832E-09 |
Normal-vs-AfricanAmerican |
1.72917999999855E-05 |
Normal-vs-Asian |
5.549700E-02 |
Caucasian-vs-AfricanAmerican |
3.771800E-01 |
Caucasian-vs-Asian |
8.652400E-01 |
AfricanAmerican-vs-Asian |
6.086400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.68310032577779E-10 |
Normal-vs-Female |
1.155280E-04 |
Male-vs-Female |
1.319840E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.8631299999905E-05 |
Normal-vs-Age(41-60Yrs) |
2.93119999994484E-06 |
Normal-vs-Age(61-80Yrs) |
2.79610001818753E-09 |
Normal-vs-Age(81-100Yrs) |
3.138000E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.143200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.700600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.931400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.169000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.145600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.174400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
5.663600E-01 |
Normal-vs-Grade 2 |
3.662700E-03 |
Normal-vs-Grade 3 |
2.17410534020246E-11 |
Normal-vs-Grade 4 |
1.62447832963153E-12 |
Grade 1-vs-Grade 2 |
1.233750E-01 |
Grade 1-vs-Grade 3 |
6.648900E-04 |
Grade 1-vs-Grade 4 |
1.96769999960544E-07 |
Grade 2-vs-Grade 3 |
3.91340000005513E-06 |
Grade 2-vs-Grade 4 |
5.06550357215474E-12 |
Grade 3-vs-Grade 4 |
4.408500E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.004000E-01 |
Normal-vs-ccB subtype |
1.90836235702818E-12 |
ccA subtype-vs-ccB subtype |
4.31710223125492E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.91839999996724E-07 |
Normal-vs-N1 |
3.98590000005861E-07 |
N0-vs-N1 |
3.567700E-02 |
|
|